West Pharmaceutical Services Inc.

299.52+3.06+1.03%Vol 349.66K1Y Perf -17.65%
Jun 29th, 2022 16:04 DELAYED
BID220.00 ASK360.39
Open295.46 Previous Close299.52
Pre-Market- After-Market-
 - -%  - -
Target Price
380.25 
Analyst Rating
Moderate Buy 1.80
Potential %
26.95 
Finscreener Ranking
★★     46.22
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★+     48.40
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★★★     68.49
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
★★+     43.23
Price Range Ratio 52W %
11.85 
Earnings Rating
Sell
Market Cap22.19B 
Earnings Date
4th Aug 2022
Alpha0.01 Standard Deviation0.08
Beta1.18 

Today's Price Range

291.40300.49

52W Range

275.89475.35

5 Year PE Ratio Range

33.80103.80

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
0.21%
1 Month
-6.75%
3 Months
-28.35%
6 Months
-36.45%
1 Year
-17.65%
3 Years
139.33%
5 Years
216.89%
10 Years
1 129.37%

TickerPriceChg.Chg.%
WST299.523.06001.03
AAPL139.231.79001.30
GOOG2 245.13-6.3000-0.28
MSFT260.263.78001.47
XOM88.12-3.3800-3.69
WFC39.71-0.4700-1.17
JNJ176.990.05000.03
FB196.640.99000.51
GE63.69-2.1900-3.32
JPM115.30-0.5200-0.45
Financial StrengthValueIndustryS&P 500US Markets
2.00
2.90
0.11
0.14
93.20
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
41.30
26.70
31.00
17.70
23.74
RevenueValueIndustryS&P 500US Markets
2.88B
38.89
16.92
12.53
DividendsValueIndustryS&P 500US Markets
0.24
0.72
5.60
6.51
Payout ratio11.00
Earnings HistoryEstimateReportedSurprise %
Q01 20222.182.305.50
Q04 20211.922.046.25
Q03 20211.822.0613.19
Q02 20211.742.4641.38
Q01 20211.422.0544.37
Q04 20201.131.3418.58
Q03 20201.011.1513.86
Q02 20200.911.2537.36
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.19-5.60Negative
9/2022 QR2.32-0.43Negative
12/2022 FY9.330.54Positive
12/2023 FY10.30-0.48Negative
Next Report Date4th Aug 2022
Estimated EPS Next Report2.19
Estimates Count3
EPS Growth Next 5 Years %10.40
Volume Overview
Volume349.66K
Shares Outstanding74.08K
Shares Float56.90M
Trades Count8.90K
Dollar Volume104.17M
Avg. Volume416.96K
Avg. Weekly Volume378.43K
Avg. Monthly Volume433.08K
Avg. Quarterly Volume439.37K

West Pharmaceutical Services Inc. (NYSE: WST) stock closed at 299.52 per share at the end of the most recent trading day (a 1.03% change compared to the prior day closing price) with a volume of 349.66K shares and market capitalization of 22.19B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 9200 people. West Pharmaceutical Services Inc. CEO is Eric Mark Green.

The one-year performance of West Pharmaceutical Services Inc. stock is -17.65%, while year-to-date (YTD) performance is -36.14%. WST stock has a five-year performance of 216.89%. Its 52-week range is between 275.89 and 475.35, which gives WST stock a 52-week price range ratio of 11.85%

West Pharmaceutical Services Inc. currently has a PE ratio of 33.60, a price-to-book (PB) ratio of 9.59, a price-to-sale (PS) ratio of 7.84, a price to cashflow ratio of 35.60, a PEG ratio of 2.32, a ROA of 23.27%, a ROC of 28.73% and a ROE of 33.77%. The company’s profit margin is 23.74%, its EBITDA margin is 31.00%, and its revenue ttm is $2.88 Billion , which makes it $38.89 revenue per share.

Of the last four earnings reports from West Pharmaceutical Services Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.19 for the next earnings report. West Pharmaceutical Services Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for West Pharmaceutical Services Inc. is Moderate Buy (1.8), with a target price of $380.25, which is +26.95% compared to the current price. The earnings rating for West Pharmaceutical Services Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

West Pharmaceutical Services Inc. has a dividend yield of 0.24% with a dividend per share of $0.72 and a payout ratio of 11.00%.

West Pharmaceutical Services Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.41, ATR14 : 9.22, CCI20 : -9.07, Chaikin Money Flow : -0.08, MACD : -4.43, Money Flow Index : 54.43, ROC : 2.05, RSI : 48.59, STOCH (14,3) : 66.15, STOCH RSI : 0.71, UO : 60.64, Williams %R : -33.85), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of West Pharmaceutical Services Inc. in the last 12-months were: Kimberly Banks MacKay (Option Excercise at a value of $114 430), Quintin J. Lai (Option Excercise at a value of $1 285 616), Quintin J. Lai (Sold 17 688 shares of value $7 435 942 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (60.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (40.00 %)
2 (40.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.80
Moderate Buy
1.80
Moderate Buy
1.80

West Pharmaceutical Services Inc.

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (77% of 2020 sales) and contract-manufactured products (23%). It generates 55% of its revenue from international markets and 45% from the United States.

CEO: Eric Mark Green

Telephone: +1 610 594-2900

Address: 530 Herman O. West Drive, Exton 19341-0645, PA, US

Number of employees: 9 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

55%45%

Bearish Bullish

62%38%

News

Stocktwits